Navigation Links
Groups in Medical Technology

Study Shows Brain Fitness can Save Medicare Billions

... participants were divided into three intervention groups and a no contact control group. The intervention groups received classroom training in reasoning or ... group, after adjustment for differences in the groups (or $223 on an unadjusted basis.) The differences ...

Wyeth Reports Publication of Phase 3 Data for Bazedoxifene/Conjugated Estrogens, an Investigational Compound Being Studied for the Treatment of Menopausal Symptoms

... events were similar among the active treatment groups and placebo. About SMART-1 SMART-1 ... clinically important differences among treatment groups and no trends of concern. The incidences of ... These results suggest that women in the BZA/CE groups gained bone mass while women in the placebo ...

Rigel's R788 Significantly Improves Rheumatoid Arthritis in Phase 2b Clinical Trial

... of 457 patients treated for up to 6 months. The groups treated with 100 mg of R788 bid (twice a day) and ... group. The efficacy results for the two dosing groups were comparable, although the response rates for ... with strong efficacy and good tolerability in the groups of patients with RA who have failed to respond to ...

5-Year Study Published in Diabetologia Demonstrated Long-Term Safety of Lantus(R) Compared to NPH

... retinopathy was similar in the two treatment groups over the long-term course of treatment. This ... at study end were similar in both treatment groups (Lantus(R): 14.2%, NPH: 15.7%; 95% CI: -7.02, ... to differences in blood glucose control. Both groups had comparable HbA1c at study end (mean HbA1c ...

King Pharmaceuticals Showcases Data From Pain Pipeline of Medicines Designed to Deter Common Methods of Non-Therapeutic Use

... doses of niacin. Volunteers were broken into two groups (fed and fasted) and were provided varying doses ... develops after repeat administration. Three groups of participants received different doses of ... approximately 75 percent of all volunteers in all groups rated the tolerability of study drugs as easy to ...

Two-Year Data Show Patients Receiving SIMPONI(TM) (golimumab) Experienced Sustained Improvement in Signs and Symptoms of Psoriatic Arthritis and Ankylosing Spondylitis

... ACR 20 response at week 14 for combined SIMPONI groups and individual SIMPONI dose groups vs. placebo. At week 16, patients with ... ACR 20 response at week 14 for combined SIMPONI groups and individual SIMPONI ...

Arena Pharmaceuticals Announces Lorcaserin Data Demonstrating Highly Significant Categorical and Absolute Weight Loss and Improvements in Secondary Endpoints Associated with Cardiovascular Risk

... events were similar in the lorcaserin and placebo groups for Year 1 and Year 2 (7.1% vs. 6.7% and 3.0% vs. ... between the active-product and placebo-treated groups is at least 5% and the difference is ... placebo-treated group, and the difference between groups is statistically significant. About Arena ...

Stand Up To Cancer Awards $73.6 Million for Novel, Groundbreaking Cancer Research

... have at least two members from patient advocacy groups to ensure that the perspective of the patients ... encourage collaborative fundraising efforts by groups of various sizes all over the country. A novel ... Ziffren. Representatives of 24 patient advocacy groups are members of SU2C's Advocate Advisory Council. ...

Results of Two Phase 3 CAPACITY Studies of Pirfenidone in IPF Presented at American Thoracic Society (ATS)

... of Grade 3 adverse events in the pirfenidone groups in both studies, there was no difference in ... patients in the 2403 mg pirfenidone and placebo groups across both CAPACITY studies who discontinued ... abnormalities was similar between treatment groups in both studies. In six of the tests, Grade 3/4 ...

Two-Year Phase III Data Presented at AAN 61st Annual Meeting Show Positive Outcome of Cladribine Tablets in Patients With Multiple Sclerosis

... results from both Cladribine Tablets treatment groups in the study demonstrated a statistically ... higher in the Cladribine Tablets treatment groups than in the placebo group. Over the two-year ... System Organ Class in both cladribine treatment groups were comparable to those observed in the placebo ...

Neurocrine Announces Top-Line Results From 702 Study (Lilac PETAL Study) of Elagolix for Treatment of Endometriosis Pain

... improved significantly in both elagolix treatment groups compared to placebo (elagolix 150 mg, p<0.01; ... was markedly higher in the elagolix treatment groups when compared to placebo (elagolix 150 mg, ... at baseline and decreased across all treatment groups by approximately -0.25 points. The results from ...

Unexpected Side Effect: Makes You Happier

... a control that engaged in no special activity. groups that did an activity engaged in the activity for ... follow-ups. Participants in the other three groups did not have similar beneficial outcomes on this ... life. While such benefits have been shown across groups in studies, individual results will vary, and ...

Merck Serono's Safinamide Significantly Improved Motor Function in Patients With Advanced Parkinson's Disease in a Phase III Pivotal Trial

... Analyzed to Date Were met in Both Safinamide Dose groups Merck Serono, a division of Merck KGaA, ... functioning. The two safinamide treatment groups of the study (receiving either safinamide 50 mg ... The differences between both safinamide dose groups and placebo were statistically significant ...

Positive Phase II Study of Pacira's EXPAREL(TM) (DepoBupivacaine) in Hernia Repair Presented at the Postgraduate Assembly in Anesthesiology (PGA)

... trend toward lower opioid use in all EXPAREL groups compared to active control -- More ... surgery ranged from 21 - 31 across all EXPAREL groups compared to 45 - 48 for bupivacaine as measured ... control. -- More patients in the EXPAREL groups completely avoided opioids 71% to 83% across ...

Research Explores the Effects of Stem Cell Source and Patient Age on Stem Cell Transplantation Outcomes

... durable responses and prolonged survival in many groups of patients." Blood cancers - leukemia, ... from 1995 to 2005 were stratified into four groups by patient age for comparison: ages 40 to 54, 54 ... Rates of relapse were similar across all age groups (29-30 percent at three years). Additionally, no ...

Study Showed Prevention of Heart Attacks Within Three Months After Hospitalization Significantly Averted Future Heart Attacks and Death

... period. The median follow-up time for both groups was 4.2 years. In the retrospective analysis, ... 58 percent). The median follow-up time for both groups was 4.2 years. The study was conducted at Duke ... Ph.D., with support from the Health Outcomes groups at Daiichi Sankyo and Lilly. About Coronary ...

Video: Sirion Therapeutics Launches Durezol for Postoperative Ocular Inflammation and Pain

... the placebo BID group (P < 0.001). Both Durezol groups maintained superiority over the placebo ... and statistically significant for the Durezol groups versus the placebo groups in both the QID and BID studies as early as Day ...

Four Alzheimer's Clinical Trials Address a Variety of Treatment Targets - Amyloid, Tau, Synapse Formation

... with mild Alzheimer's (mean MMSE in both groups = 23.3) were randomized 1:1 to receive ... patients in both the tarenflurbil and placebo groups had declined approximately seven points on the ... "The fact that both the drug-treated and placebo groups declined over the course of the trial - and that ...

New Meta-Analysis Confirms Safety Profile for NeoRecormon in Treating Anaemia in Cancer Patients

... TEEs (1% vs. 1%) for the NeoRecormon and control groups respectively. About the meta-analysis - ... robust overall analysis and sub-analyses of groups of special interest, such as those with ... the world's leading research-focused healthcare groups in the fields of pharmaceuticals and diagnostics. ...

Sangamo BioSciences Announces Presentation of Phase 1b ZFP Therapeutic Data at American Diabetes Association Meeting

... Subjects have been randomized to one of two groups in a 2:1 ratio. The larger group (approximately ... Subjects were randomized to one of two groups in a 2:1 ratio. The larger group (approximately ... Subjects will again be randomized to one of two groups in a 2:1 ratio. The larger group (approximately ...

CellCept(R) and a Reduced Level of CNI Shows Trend Towards Preservation of Kidney Function Versus a Standard-Dose CNI

... did not differ among treatment groups with living donors accounting for approximately ... of CellCept and the standard level CNI group. groups Patients Graft Loss BPAR ... the world's leading research-oriented healthcare groups with core businesses in pharmaceuticals and ...

Final Results of the CellCept(R) Spare the Nephron (STN) Study Show Maintenance Therapy is Associated with Improved Renal Function

... time from transplant to randomization in both groups was 117 days. Baseline characteristics and measured GFR values were similar in the treatment groups and 98 patients in the CellCept-based regimen ... the world's leading research-oriented healthcare groups with core businesses in pharmaceuticals and ...

The 'Anatomy' of Clinical Trials: 'Grey's' Season Finale Leaves Public in the Dark About the Myths and Realities

... Coalition of Cancer Cooperative groups sheds light on the fact that cancer clinical ... trials. The Coalition of Cancer Cooperative groups is a nonprofit organization with a goal to ... Groups The Coalition of Cancer Cooperative groups is the nation's only nonprofit organization of ...

Alba Therapeutics Announces the Presentation of Results of a Phase IIa Clinical Trial for Larazotide Acetate for the Treatment of Celiac Disease at the Digestive Disease Week Conference

... randomized into seven drug-treated and placebo groups and challenged three times a day with gluten or ... ratio from Day 0 to Day 14, the treatment groups showed a dose dependent protection from ... * In the highest dose active treatment groups of 4 and 8 mg, the LAMA ratio did not ...

Alseres Pharmaceuticals Announces 12 Month Interim Results from the Phase I/IIa Cethrin(R) Clinical Trial in Acute Spinal Cord Injury

... The measurement is made by assessing five muscle groups in each arm and leg on a 0-5 point scale for a ... cervical patients from the 1 and 3 mg dose groups demonstrating improvement of at least 2 AIS ... improvement in both the 1 and 3 mg dosage groups in the cervical-injured patients with mean ...

TYKERB(R) (Lapatinib) to be Investigated in Landmark Early Breast Cancer Trial

... proud to collaborate with such esteemed research groups as BIG and SOLTI for the study of TYKERB in this ... in 1996, BIG now constitutes a network of 41 groups in Europe, Canada, Latin America, Australia/New ... Its partners are other international academic groups and pharmaceutical and research companies. SOLTI ...

Results of Phase 3 Study Show Tapentadol IR Relieves Acute Pain and Offers Favorable Gastrointestinal Tolerability Profile

... The 50 mg and 75 mg tapentadol IR treatment groups showed similar efficacy to the group treated with ... only four or seven percent of the tapentadol IR groups -- treated with 50 mg and 75 mg respectively -- ... The most common adverse events in both treatment groups included nausea, dizziness and vomiting. "We ...

New Data From Phase 3 Study Suggests Tapentadol Immediate Release Effective for Acute Pain From Common Foot Surgery

... with tapentadol. All tapentadol IR treatment groups showed a statistically significant improvement in ... for tapentadol IR and oxycodone IR treatment groups with a dose-dependent pattern of increasing ... emergent adverse events in both active treatment groups included nausea, vomiting, constipation, ...

Shire's Investigational Nonstimulant ADHD Treatment INTUNIV(TM) (Guanfacine Extended Release) Demonstrated Significant Efficacy in Reducing ADHD Symptoms at All Measured Time Points Up to 24 Hours Postdose

... score from baseline to endpoint. All patient groups treated with INTUNIV showed significantly greater ... CPRS-R scores for all weight adjusted dose groups treated with INTUNIV when compared to placebo for ... Findings from the analysis showed that all groups treated with INTUNIV responded to the medication ...

Microbia and Forest Laboratories Announce Preliminary Results of Linaclotide Phase 2b Studies

... weekly SBM frequency rate across all treatment groups was 2.31. Patients who received once-daily dosing ... for at least two of the four linaclotide dose groups for each endpoint. Linaclotide was well ... for at least two of the four linaclotide dose groups for each endpoint. Linaclotide was well tolerated ...

Alexza's AZ-104 (Staccato(R) Loxapine) Phase 2a Trial Meets Primary Endpoint of 2-Hour Pain Relief in Patients with Migraine Headache

... analysis for pain relief response, all three dose groups were statistically superior (p < 0.05) to placebo ... analysis for pain free response, all three dose groups were statistically superior (p < 0.05) to placebo ... for the 5 mg (16%) and the 1.25 mg (21%) dose groups were not statistically significant. Important ...

REMICADE-Treated Patients Experienced Rapid and Substantial Improvement in Psoriasis in Critical Regions of Body

... neck-related psoriasis in the combined REMICADE groups (3 mg/kg and 5 mg/kg) versus placebo were as ... for trunk psoriasis in the combined REMICADE groups (3 mg/kg and 5 mg/kg) versus placebo were as ... improvement. Patients in the combined REMICADE groups (3mg/kg and 5 mg/kg) experienced similar ...

Rigel's R788 Demonstrates Significant Improvement in Rheumatoid Arthritis in Phase 2 Clinical Study

... in a recently completed Phase 2 clinical trial. groups treated with R788 at 100mg and 150mg po bid ... efficacy results for the 100mg and the 150mg dose groups were fairly comparable. Dramatically, the onset of the effect in these dose groups occurred as early as one week after initiation of ...

NicOx' Naproxcinod Phase 3 Results Presented at American College of Rheumatology

... the naproxcinod 750 mg and 375 mg bid treatment groups reported event rates of 17.0% and 12.9%, respectively and the naproxen and placebo bid groups reported event rates of 23.6% and 12.2%, ... differences among the four treatment groups for any baseline variables, including ...

Consumer Advocates Support Patent Office on Stem Cell Patent Rejection

... and the claims remain unpatentable, two consumer groups said today. In formal comments filed Friday the ... filed declarations supporting the consumer groups and the PTO's earlier finding that the work done ... case are relevant to the other two. Since the groups filed their challenge, WARF has substantially ...

Medivation's MDV3100 Demonstrates Substantial PSA Reductions in First Patient Groups Treated in Phase 1-2 Hormone Refractory Prostate Cancer Trial

... - Early study data from the two lowest dose groups show dose-dependent PSA ... the six patients enrolled in the first two dose groups of its ongoing Phase 1-2 trial in ... is enrolling patients in up to seven dose groups of three patients each at escalating doses, with ...

Human Genome Sciences Announces Full Presentation of Quality-of-Life Results From Phase 2b Trial of Albuferon(R) for Hepatitis C

... that patients in the Albuferon treatment groups reported fewer missed days of work and less ... Working patients in all Albuferon treatment groups recorded fewer days of missed work than was ... alfa-2a treatment group. All Albuferon groups showed less impairment of health-related quality ...

Ethics Group Asks USAID Inspector General to Investigate Legality of Grants to Soros Groups

... is violating federal law by funding nonprofit groups operating needle exchange programs for drug users ... collaborates with Soros-affiliated nonprofit groups to skirt the law. Between 2001 and 2007 USAID ... NLPC today released a Special Report titled Soros groups Receive Taxpayer Funds: State Department ...

Actress and Mother Jennifer Garner Joins American Lung Association to Encourage Americans to Get an Influenza Vaccination

... encouraging influenza vaccination among target groups -- according to recommendations by the Centers ... Americans who fall into one or more of the groups CDC recommends for annual influenza vaccination. ... disease or spreading it to others. Other target groups include: adults and children with a chronic ...

Sugammadex Trials Demonstrate Rapid Recovery from Profound Neuromuscular Blockade During General Anesthesia

... events (AEs) for the sugammadex and neostigmine groups regardless of relationship to the study drug ... (70 vs. 76%) and nausea (38 vs. 50%). For both groups no serious drug-related adverse events were ... for the rocuronium/sugammadex and succinylcholine groups regardless of relationship to the study drug were ...
Other Contents
(Date:7/27/2014)... like bacteria and fungi can evade treatment by acquiring ... drugs. These permanent mutations were once thought to be ... a new study has shown that microorganisms can use ... epimutations -- to gain the benefits of drug resistance ... discovered in a fungus called Mucor circinelloides, it is ...
(Date:7/27/2014)... Using data from over 18,000 patients, scientists have ... involved in Parkinson,s disease, including six that had ... Nature Genetics , was partially funded by ... by scientists working in NIH laboratories. , "Unraveling ... understanding the multiple mechanisms involved in this complex ...
(Date:7/25/2014)... and some of the smoke from those fires is drifting ... the Moderate Resolution Imaging Spectroradiometer (MODIS) aboard the Aqua satellite ... over the Great Lakes region of the United States. ... 23, 2014 (first image feature highlighted below) clearly shows the ... In the image, it is over Manitoba and parts ...
Breaking Biology News(10 mins):Scientists discover new, noncommittal mechanism of drug resistance 2Scientists discover new, noncommittal mechanism of drug resistance 3NIH scientists find 6 new genetic risk factors for Parkinson's 2
(Date:7/27/2014)... Manufacturers of natural ingredient beauty creams are now ... younger appearance. The Cherry News company has published its ... women explore the availabilities from U.S. retailers at ... the posted guide on the Cherry News website provide ... to some natural ingredient formulas is the high sticker ...
(Date:7/27/2014)... CA (PRWEB) July 27, 2014 Ticket Down ... Tickets at The Forum in Inglewood, California on November 15th. ... and diehard fans can expect to hear songs from this amazing ... of Summer concert in Inglewood, California at The Forum will be ... starting at 10:00 a.m. today local time TicketDown.com. This popular ...
(Date:7/27/2014)... 2014 The constant expansion of companies ... demand for enterprise video. Additional factors that have increased ... areas such as corporate communication, learning and development, security ... all these factors the enterprise video market value has ... reach $35.57 billion in 2018 with a compound annual ...
(Date:7/27/2014)... The report, “Oil Filter & Fuel Filter Market by ... (OE & Aftermarket), Filter Type (Oil & Fuel), Fuel ... & Forecast to 2018”, defines and segments the global ... forecasting of the global volume and revenue. The market ... revenue of $6.1 billion in 2018, while fuel filter ...
(Date:7/27/2014)... European Bromine market report defines and segments the Bromine market ... market in European region comprises of four major countries. They ... forms a dominant share of Bromine market influences the demand ... through the TOC of the Europe Bromine Market report, to ... the TOC of the Europe Bromine Market report. The report ...
Breaking Medicine News(10 mins):Health News:Natural Eye Cream Buyer's Guide Published Online at Consumer News Website 2Health News:5 Seconds of Summer Tickets at The Forum in Inglewood (Los Angeles), CA Now Available For Sale at Ticket Down 2Health News:North America Enterprise Video Market is Expected to Reach $13.00 billion in 2018 - New Report by MicroMarket Monitor 2Health News:North America Enterprise Video Market is Expected to Reach $13.00 billion in 2018 - New Report by MicroMarket Monitor 3Health News:North America Enterprise Video Market is Expected to Reach $13.00 billion in 2018 - New Report by MicroMarket Monitor 4Health News:Oil Filter & Fuel Filter Market Worth $18.6 Billion by 2018 - Report by MarketsandMarkets 2Health News:Oil Filter & Fuel Filter Market Worth $18.6 Billion by 2018 - Report by MarketsandMarkets 3Health News:Oil Filter & Fuel Filter Market Worth $18.6 Billion by 2018 - Report by MarketsandMarkets 4Health News:Oil Filter & Fuel Filter Market Worth $18.6 Billion by 2018 - Report by MarketsandMarkets 5Health News:Europe Bromine Market is Expected to Reach $111.6 Million in 2018 - New Report by MicroMarket Monitor 2Health News:Europe Bromine Market is Expected to Reach $111.6 Million in 2018 - New Report by MicroMarket Monitor 3Health News:Europe Bromine Market is Expected to Reach $111.6 Million in 2018 - New Report by MicroMarket Monitor 4
Other TagsOther Tags